全文获取类型
收费全文 | 294篇 |
免费 | 8篇 |
专业分类
各国政治 | 12篇 |
工人农民 | 2篇 |
世界政治 | 13篇 |
外交国际关系 | 37篇 |
法律 | 182篇 |
政治理论 | 55篇 |
综合类 | 1篇 |
出版年
2024年 | 10篇 |
2023年 | 37篇 |
2022年 | 2篇 |
2021年 | 11篇 |
2020年 | 14篇 |
2019年 | 6篇 |
2018年 | 5篇 |
2017年 | 5篇 |
2016年 | 8篇 |
2015年 | 10篇 |
2014年 | 16篇 |
2013年 | 48篇 |
2012年 | 17篇 |
2011年 | 14篇 |
2010年 | 4篇 |
2009年 | 9篇 |
2008年 | 13篇 |
2007年 | 8篇 |
2006年 | 12篇 |
2005年 | 6篇 |
2004年 | 10篇 |
2003年 | 4篇 |
2002年 | 4篇 |
2001年 | 2篇 |
2000年 | 3篇 |
1998年 | 15篇 |
1997年 | 1篇 |
1996年 | 3篇 |
1995年 | 1篇 |
1994年 | 1篇 |
1991年 | 1篇 |
1984年 | 1篇 |
1973年 | 1篇 |
排序方式: 共有302条查询结果,搜索用时 15 毫秒
301.
Roberto Catanesi M.D. Giovanna Punzi M.D. William C. Rodriguez III Ph.D. Biagio Solarino M.D. Ph.D. Giancarlo Di Vella M.D. Ph.D. 《Journal of forensic sciences》2014,59(1):274-280
Folie à deux is a rare clinical syndrome characterized by the transference of delusional ideas from one person to one or more other people in close association with the primary affected patient. Mummification indicates the preservation of the corpse of a person for a variable period of time. A brief review of the literature in this field is presented, and an exceptional case is described, characterized by the association of both these rare phenomena. The case is an example of folie à fammille which developed out of a condition of extreme religiousness and seclusion of an entire family. The shared psychosis led to the horrible death of some of the family members, while the last surviving member of the family lived for more than a year and a half with their mummified remains. The Judge commissioned a forensic psychiatry assessment to verify the survivor's ability to bear witness. The development of the psychiatric syndrome and its consequences are extensively discussed. 相似文献
302.
Antonanzas F Juarez-Castello C Rodriguez-Ibeas R 《Health economics, policy, and law》2011,6(3):391-403
In this paper, we characterise the risk-sharing contracts that health authorities can design when they face a regulatory decision on drug pricing and reimbursement in a context of uncertainty. We focus on two types of contracts. On the one hand, the health authority can reimburse the firm for each treated patient regardless of health outcomes (non risk-sharing). Alternatively, the health authority can pay for the drug only when the patient is cured (risk-sharing contract). The optimal contract depends on the trade-off between the monitoring costs, the marginal production cost and the utility derived from treatment. A non-risk-sharing agreement will be preferred by the health authority, if patients who should not be treated impose a relatively low cost to the health system. When this cost is high, the health authority would prefer a risk-sharing agreement for relatively low monitoring costs. 相似文献